Does ROZANOLIXIZUMAB-NOLI Cause Injection site swelling? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site swelling have been filed in association with ROZANOLIXIZUMAB-NOLI. This represents 1.4% of all adverse event reports for ROZANOLIXIZUMAB-NOLI.
5
Reports of Injection site swelling with ROZANOLIXIZUMAB-NOLI
1.4%
of all ROZANOLIXIZUMAB-NOLI reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site swelling From ROZANOLIXIZUMAB-NOLI?
Of the 5 reports.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB-NOLI. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB-NOLI Cause?
Myasthenia gravis (57)
Drug ineffective (51)
Headache (48)
Nausea (29)
Diarrhoea (27)
Fatigue (27)
Dyspnoea (19)
Hospitalisation (19)
Vomiting (17)
Therapy interrupted (15)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which ROZANOLIXIZUMAB-NOLI Alternatives Have Lower Injection site swelling Risk?
ROZANOLIXIZUMAB-NOLI vs RUBIDIUM RB-82
ROZANOLIXIZUMAB-NOLI vs RUCAPARIB
ROZANOLIXIZUMAB-NOLI vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB-NOLI vs RUFINAMIDE
ROZANOLIXIZUMAB-NOLI vs RUPATADINE